On June 24, 2016, the PMPRB released its long awaited consultation paper “PMPRB Guidelines Modernization – Discussion Paper, June 2016”. Are you interested in learning more about the potential repercussions of these changes on Canadian drug prices and implications for pharmaceutical companies? PDCI Market Access Inc., Canada’s leading pricing and reimbursement ... Read More


The Patented Medicines Prices Review Board (PMPRB) has released their highly anticipated Strategic Plan 2015-2018. The PMPRB’s three-year strategic plan includes four new strategic objectives, a reinvigorated mission statement, and a vision as to how the organization can work with partners and stakeholders in advancing the common goal of ... Read More


Interested in learning more about new developments at the pan-Canadian Pharmaceutical Alliance (pCPA)? Curious to know more about private payer Product Listing Agreements (PLAs) in Canada? PDCI Market Access (PDCI) is hosting a free webinar on Friday, October 30, 2015 from 11:00 AM -12:00 PM EDT titled Market Access Climate Change: the ... Read More


PDCI Presentation at Women In Bio (Montreal Chapter) – April 16th, 2015 The Greater Montreal Chapter of Women In Bio will present a half-day conference followed by a keynote lunch on the latest developments and trends affecting market access ... Read More


PDCI's pre-conference workshop at the upcoming Canadian Institute: Pharma Symposium Canada 2015 has been cancelled. For those who may still be interested in the workshop, PDCI is more than happy to provide the workshop in the form of a Webinar or in-house training. Please contact Andrew Brooke for more information on ... Read More